In my daily discussions with the BRAIN community, I hear the tension between small and big science: a proxy argument for exploring biology versus building tools. Individual labs do creative biology, so why fund large teams that churn out lots of data but aren’t testing hypotheses?
My answer is simple: Diseases don’t care about funding mechanisms.